28 June 2024
CVS Group
plc
("CVS" or
the "Company")
Exercise of Options and Total
Voting Rights
CVS, one of the UK's leading
providers of integrated veterinary services, confirms that certain
employees have exercised options during June under the CVS Group
2020 SAYE Plan (2020/2024) totalling 11,345 ordinary shares of 0.2
pence each ("Ordinary Shares").
The issuance of shares in connection
with the SAYE Exercise was partially satisfied by 481 Ordinary
Shares held by the CVS Group Employee Benefit Trust (the
"EBT"). Following the SAYE Exercise, a total of 164 Ordinary
Shares are held by the EBT, representing approximately 0.0002% of
the Company's total voting rights.
The sum of 10,864 new Ordinary Shares
were issued to partially satisfy the balance of Ordinary Shares
arising from the SAYE Exercise. Admission of the 10,864 new
Ordinary Shares has been satisfied by the Company's block listing
admitted to the London Stock Exchange on 30 December
2021.
Following the issue of these new
Ordinary Shares, which rank pari passu in all respects with the
Company's existing Ordinary Shares, the Company has a total issued
share capital of 71,732,133 Ordinary Shares, each carrying one
voting right. The Company holds no Ordinary Shares in treasury and
the total number of voting rights is therefore
71,732,133.
This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest, in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
Contacts:
CVS Group
plc
via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP
(Nominated Adviser &
Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steele / Andrew
Clark / Lalit Bose
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo
Bonser
Camarco
(Financial
PR)
Geoffrey
Pelham-Lane
+44 (0)7733 124
226
Ginny Pulbrook
+44
(0)7961 315 138
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed
provider of veterinary services with operations in the UK and
Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and
dedicated clinical teams and support colleagues at the core of its
strategy.
The Group operates c.460 veterinary
practices across its two territories, including specialist referral
hospitals and dedicated out-of-hours sites. Alongside the core
Veterinary Practices division, CVS operates Laboratories (providing
diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and
third-party practices) and an online retail business ("Animed
Direct").
The Group employs c.9,000 personnel,
including c.2,400 veterinary surgeons and c.3,400
nurses.